Bioprocess Automation Market Report 2026
Bioprocess Automation Market Report 2026
Global Outlook – By Component Of Process Control System (Sensors, Actuators, Controllers), By Scale Of Operation (Preclinical Operations, Clinical Operations, Commercial Operations), By Mode Of Operation (Batch, Fed-Batch, Perfusion), By Compatibility With Bioprocessing Systems (Single-Use Systems, Stainless Steel, Other Bioprocessing Systems) – Market Size, Trends, Strategies, and Forecast to 2035
Bioprocess Automation Market Overview
• Bioprocess Automation market size has reached to $6.4 billion in 2025 • Expected to grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: The Role Of Personalized Medicine In Driving Bioprocess Automation Market Growth • Market Trend: Innovative Bioreactor Solutions Revolutionizing Bioprocessing Operations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Bioprocess Automation Market?
Bioprocess automation is using automated systems to monitor and control the bioprocessing workflow, which involves living cells, organisms, or components to produce biological products such as biopharmaceuticals. Biopharmaceutical businesses use bioprocess automation for better process control and optimization, higher product quality, decreased variability, increased throughput and efficiency, cost savings, and scalability. The main components of bioprocess automation are sensors, actuators, and controllers. Sensors are devices that detect and respond to inputs from the physical environment, converting them into electronic signals, which are used to monitor various parameters such as temperature, pH, dissolved oxygen, and pressure. The scale of operation includes preclinical operations, clinical operations, and commercial operations with batch, fed-batch, and perfusion modes of compatibility with bioprocessing systems include single-use systems, stainless steel, and others.
What Is The Bioprocess Automation Market Size and Share 2026?
The bioprocess automation market size has grown rapidly in recent years. It will grow from $6.4 billion in 2025 to $7.21 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth of biopharmaceutical manufacturing, increasing complexity of biologics production, adoption of programmable control systems, demand for consistent product quality, expansion of clinical manufacturing operations.What Is The Bioprocess Automation Market Growth Forecast?
The bioprocess automation market size is expected to see rapid growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing investments in continuous bioprocessing, rising demand for scalable automation platforms, growth of cell and gene therapy manufacturing, integration of AI-driven process optimization, expansion of smart biomanufacturing facilities. Major trends in the forecast period include increasing adoption of automated bioprocess control platforms, rising integration of real-time process analytics, growing use of single-use bioprocessing automation, expansion of closed-loop process control systems, enhanced focus on data integrity and compliance.Tariff Impact On Bioprocess Automation Market
Tariffs are affecting the bioprocess automation market by increasing costs of imported sensors, control valves, automation software licenses, industrial controllers, and analytical instruments used in biopharmaceutical manufacturing. Commercial-scale bioprocessing facilities in North America and Europe are most impacted due to reliance on imported automation components, while Asia-Pacific faces cost pressures on system exports. These tariffs are raising system integration costs and slowing automation upgrades. At the same time, they are supporting localized production of automation hardware, regional software development, and partnerships focused on compliant and cost-efficient bioprocess control solutions.Global Bioprocess Automation Market Segmentation
1) By Component Of Process Control System: Sensors, Actuators, Controllers 2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations 3) By Mode Of Operation: Batch, Fed-Batch, Perfusion 4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems Subsegments: 1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors 2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators 3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other ControllersWhat Is The Driver Of The Bioprocess Automation Market?
The increasing number of personalized medicines is expected to drive the growth of the bioprocess automation market going forward. Personalized medicine is a medical approach that customizes healthcare decisions, practices, interventions, and treatments according to the unique characteristics of each patient. Bioprocess automation supports personalized medicine by enabling precise and scalable production of patient-specific therapies. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the rising number of personalized medicines is fueling the growth of the bioprocess automation industry.What Is The Driver Of The Bioprocess Automation Market?
The increasing number of personalized medicines is expected to drive the growth of the bioprocess automation market going forward. Personalized medicine is a medical approach that customizes healthcare decisions, practices, interventions, and treatments according to the unique characteristics of each patient. Bioprocess automation supports personalized medicine by enabling precise and scalable production of patient-specific therapies. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the rising number of personalized medicines is fueling the growth of the bioprocess automation industry.Global Bioprocess Automation Market Trends and Insights
Major companies operating in the bioprocess automation market are developing innovative solutions, such as bioreactors to simplify bioprocessing operations. A bioreactor is an engineered system or device that provides an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that provides technologies and services that help advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. It is easy to operate, flexible, and more efficient in the process. It was first offered in 50 and 200 L capacities. They can increase process efficiency through ergonomic improvements, production capability, and simplified supply chain operations. The X-platform bioreactors can be used to manufacture cell and gene therapies as well as viral vectors, in addition to monoclonal antibodies (mAbs).What Are Latest Mergers And Acquisitions In The Bioprocess Automation Market?
In September 2025, Thermo Fisher Scientific, a US-based life sciences and biopharma supplies leader, acquired the purification and filtration business of Solventum for an undisclosed amount. Through this acquisition, Thermo Fisher aims to strengthen its bioprocess automation offerings by expanding its downstream processing capabilities, enabling more comprehensive solutions for biologics, cell therapies, and drug manufacturing. Solventum’s purification & filtration business is a US-based international entity that provides critical filtration technologies across multiple geographies.Regional Outlook
North America was the largest region in the bioprocess automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Bioprocess Automation Market?
The bioprocess automation market includes revenues earned by entities by providing services such as process automation, instrumentation and control systems, training and support services, and maintenance and upgrades. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess automation market also includes sales of bioreactors, fermenters, laboratory information management systems (LIMS), and integrated bioprocess platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Bioprocess Automation Market Report 2026?
The bioprocess automation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess automation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Bioprocess Automation Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.21 billion |
| Revenue Forecast In 2035 | $11.52 billion |
| Growth Rate | CAGR of 12.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component Of Process Control System, Scale Of Operation, Mode Of Operation, Compatibility With Bioprocessing Systems |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Parker-Hannifin Corporation, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf SE, Repligen Corporation, BIONET Engineering, Pierre Guerin Technologies, Bioengineering AG, Genedata AG, ILS Automation LLC, INFORS HT AG, Synthace Ltd., Automated Control Concepts Inc., BlueSens gas sensor GmbH, Securecell AG, Flownamics Analytical Instruments Inc., PendoTECH LLC, Sartorius Stedim Biotech S.A. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Bioprocess Automation market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.
request a sample hereThe expected CAGR for the Bioprocess Automation market during the forecast period 2025–2030 is 12.4%.
request a sample hereMajor growth driver of the market includes: The Role Of Personalized Medicine In Driving Bioprocess Automation Market Growth in the Bioprocess Automation market. For further insights on this market,
request a sample hereThe bioprocess automation market covered in this report is segmented –
1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers
request a sample here1) By Component Of Process Control System: Sensors, Actuators, Controllers
2) By Scale Of Operation: Preclinical Operations, Clinical Operations, Commercial Operations
3) By Mode Of Operation: Batch, Fed-Batch, Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems, Stainless Steel, Other Bioprocessing Systems Subsegments:
1) By Sensors: Temperature Sensors, Pressure Sensors, Flow Sensors, Level Sensors, PH Sensors, Other Sensors
2) By Actuators: Electric Actuators, Pneumatic Actuators, Hydraulic Actuators, Other Actuators
3) By Controllers: Programmable Logic Controllers (PLC), Distributed Control Systems (DCS), Supervisory Control And Data Acquisition (SCADA), Other Controllers
Major trend in this market includes: Innovative Bioreactor Solutions Revolutionizing Bioprocessing Operations For further insights on this market,
request a sample hereMajor companies operating in the Bioprocess Automation market are Major companies operating in the bioprocess automation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Parker-Hannifin Corporation, Rockwell Automation Inc., Agilent Technologies Inc., Lonza Group AG, Waters Corporation, Getinge AB, Eppendorf SE, Repligen Corporation, BIONET Engineering, Pierre Guerin Technologies, Bioengineering AG, Genedata AG, ILS Automation LLC, INFORS HT AG, Synthace Ltd., Automated Control Concepts Inc., BlueSens gas sensor GmbH, Securecell AG, Flownamics Analytical Instruments Inc., PendoTECH LLC, Sartorius Stedim Biotech S.A.
request a sample hereMajor trends in this market include Major companies operating in the bioprocess automation market are developing innovative solutions, such as bioreactors to simplify bioprocessing operations. A bioreactor is an engineered system or device that provides an optimal and controlled environment for biological and chemical reactions. For instance, in April 2023, Cytiva, a US-based technology company that provides technologies and services that help advance and accelerate the development and manufacture of therapeutics, launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. It is easy to operate, flexible, and more efficient in the process. It was first offered in 50 and 200 L capacities. They can increase process efficiency through ergonomic improvements, production capability, and simplified supply chain operations. The X-platform bioreactors can be used to manufacture cell and gene therapies as well as viral vectors, in addition to monoclonal antibodies (mAbs).. For further insights on this market,
request a sample here